thrombin receptor peptide sfllrnp has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumbach, J; Bernlochner, I; Biasi, M; Bongiovanni, D; Buske, C; Condorelli, G; Klug, M; Laugwitz, KL; Lazareva, O; List, M; Lukas, M; Scheidt, MV; Spinner, CD; Ursu, S; Warth, S; Weidlich, S | 1 |
1 other study(ies) available for thrombin receptor peptide sfllrnp and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype.
Topics: Adult; Blood Platelets; Case-Control Studies; COVID-19; Female; Germany; Humans; Leukocytes; Male; Middle Aged; P-Selectin; Peptide Fragments; Phenotype; Platelet Glycoprotein GPIIb-IIIa Complex; SARS-CoV-2; Thrombosis | 2021 |